Champions Oncology, Inc.
$5.08
$0.13 (+2.63%)
$4.87Day Range$5.20
Key Statistics
Market Cap
$68.90M
Shares Outstanding
13.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 31, 1994
Round Lot
100
Locale
US
Trading Data
Day Open
$4.99
Day High
$5.20
Day Low
$4.87
Volume
28.9K
VWAP
$4.96
Prev Close
$4.95
Transactions
--
Acc. Volume
--
About Champions Oncology, Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836214 employees855 N. WOLFE STREET, BALTIMORE, MD, 21205410-369-0365IPO Oct 31, 1994US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000771856
- Composite FIGI
- BBG000BYGPJ9
- Share Class FIGI
- BBG001S5YHT9
- Ticker Root
- CSBR
- SIC Code
- 2836
About Champions Oncology, Inc. (CSBR) Stock
Champions Oncology, Inc. (CSBR) closed the 2026-09-17 session at $5.08, up 2.63% versus the previous close (+0.13). The stock opened at $4.99 and traded between $4.87 and $5.20 during that session. Session trading volume was 29K shares. The volume-weighted average price (VWAP) is $4.96.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
Champions Oncology, Inc. has a market capitalization of $68.9 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. CSBR is listed on the XNAS exchange. The company employs approximately 214 people. Champions Oncology, Inc. is headquartered in BALTIMORE, MD. The recorded listing date is 1994-10-31.
On this page you can find market CSBR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.